Biomarkers to predict prognosis and response to checkpoint inhibitors
2017 · International Journal of Clinical Oncology · 65 citations
https://doi.org/10.1007/s10147-017-1122-1
J
Junji Yonese
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
335
Papers
4.7K
Citations
35
h-index
102
i10-index
Junji Yonese is an academic researcher from Japanese Foundation For Cancer Research. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Bladder and Urothelial Cancer Treatments & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 35, co-authored 285 publications.
ORCID: 0000-0001-9266-4020Papers by this author
worksTherapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas
2016 · Scientific Reports · 34 citations
https://doi.org/10.1038/srep25669
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data
2020 · International Journal of Clinical Oncology · 25 citations
https://doi.org/10.1007/s10147-020-01692-z
Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer
2021 · Prostate Cancer and Prostatic Diseases · 21 citations
https://doi.org/10.1038/s41391-021-00331-6
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
2021 · International Journal of Clinical Oncology · 14 citations
https://doi.org/10.1007/s10147-021-02070-z
Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer
2013 · Quality of Life Research · 11 citations
https://doi.org/10.1007/s11136-013-0603-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat